These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3315267)

  • 1. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.
    Bruguerolle B; Philip-Joet F; Parrel M; Arnaud A
    Chronobiol Int; 1987; 4(3):381-5. PubMed ID: 3315267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies].
    Philip-Joet F; Bruguerolle B; Parrel M; Vestri R; Arnaud A
    Presse Med; 1988 Feb; 17(5):193-6. PubMed ID: 2965374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma.
    Dorow P; Steinijans VW
    Chronobiol Int; 1987; 4(3):349-57. PubMed ID: 3315265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma.
    Reinberg A; Pauchet F; Ruff F; Gervais A; Smolensky MH; Levi F; Gervais P; Chaouat D; Abella ML; Zidani R
    Chronobiol Int; 1987; 4(3):409-19. PubMed ID: 3315270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sustained-release theophylline scheduled conventionally (twice-daily, equal interval in equal amount) versus once-daily mornings or evenings on circadian pattern of bronchial patency in asthmatics.
    Frankoff HM; Smolensky MH; D'Alonzo GE; Gianotti L; Hsi B; McGovern JP
    Chronobiol Int; 1987; 4(3):421-33. PubMed ID: 3315271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrono-optimization of the time of evening administration with unequally divided twice-daily theophylline.
    Kunkel G; Steinijans VW; Borner K
    Chronobiol Int; 1987; 4(3):359-68. PubMed ID: 3315266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.
    Steinijans VW; Trautmann H; Johnson E; Beier W
    Chronobiol Int; 1987; 4(3):331-47. PubMed ID: 3315264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosinor analysis of circadian peak expiratory flow variability in normal subjects, passive smokers, heavy smokers, patients with chronic obstructive pulmonary disease and patients with interstitial lung disease.
    Casale R; Pasqualetti P
    Respiration; 1997; 64(4):251-6. PubMed ID: 9257358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term therapy with a retard theophylline preparation].
    Keller A; Bömches B; Kandt D
    Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronotherapy of bronchial asthma: circadian rhythms in peak expiratory flow. The report II: Circadian rhythms of peak expiratory flow in asthmatic patients and effect of sustained-release theophylline on various types of the circadian rhythms].
    Yoshida S; Tomioka H; Kagami M; Nakazawa T
    Arerugi; 2001 Aug; 50(8):679-88. PubMed ID: 11579519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage].
    Siemon G; Huber W; Maier-Stocker P
    Pneumologie; 1991 Nov; 45 Suppl 4():853-7. PubMed ID: 1812479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of nocturnal asthma: the role of sustained-release theophylline and oral beta-2-mimetics.
    Wilkens JH; Wilkens H; Heins M; Kurtin L; Oellerich M; Sybrecht GW
    Chronobiol Int; 1987; 4(3):387-96. PubMed ID: 3315268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy of reversible airways disease with once-daily evening doses of a controlled-release theophylline preparation.
    Goldenheim PD; Schein LK
    Ann N Y Acad Sci; 1991; 618():490-503. PubMed ID: 2006803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
    Goldenheim PD; Conrad EA; Schein LK
    Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.